TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10845879

Group type: EXPERIMENTAL
Intervention: Droloxifene (60 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conjugated estrogen (0.625 mg/d)
Number of subjects: 24
Study: 8764787

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (0.75% bupivacaine)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (2% lidocaine and 0.75% bupivacaine plus hyaluronidase)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both groups (Topical and Retrobulbar)
Number of subjects: 138
Study: 1481550

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bid
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg bid
Number of subjects: 31

Group type: COMPARATOR
Intervention: Piroxicam/Placebo (group A)
Number of subjects: 31
Study: 31849170

Group type: EXPERIMENTAL
Intervention: Increased daily walking steps for 6 months
Number of subjects: 91

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 91
Study: 29903515

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin (E/S)
Number of subjects: 14819

Group type: COMPARATOR
Intervention: placebo/simvastatin (P/S)
Number of subjects: 14819

Group type: EXPERIMENTAL
Intervention: NFS > 0.67
Number of subjects: 14819

Group type: COMPARATOR
Intervention: NFS < -1.455
Number of subjects: 14819
Study: 28395364

Group type: EXPERIMENTAL
Intervention: Oral Paracetamol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral Ibuprofen
Number of subjects: 80
Study: 26238113

Group type: EXPERIMENTAL
Intervention: Perindopril 4mg (n = 9)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Valsartan 80mg/d (n = 9)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lifestyle modification (n = 15)
Number of subjects: 33
Study: 24204974

Group type: EXPERIMENTAL
Intervention: Story booklets
Number of subjects: 413

Group type: COMPARATOR
Intervention: Standard information sheets
Number of subjects: 413
Study: 22022848

Group type: EXPERIMENTAL
Intervention: In-person, targeted education
Number of subjects: 24

Group type: COMPARATOR
Intervention: Delayed education (control)
Number of subjects: 24
Study: 18837771

Group type: EXPERIMENTAL
Intervention: TJ-48 (7.5 g/d, n=22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 42
Study: 17076223

Group type: EXPERIMENTAL
Intervention: Combination of bisoprolol and enalapril with trimetasidine (70 mg/day from postmyocardial day 7-10 for 6 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Combination of bisoprolol and enalapril without trimetasidine
Number of subjects: 75
Study: 12687510

Group type: EXPERIMENTAL
Intervention: Nurse specialist care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Inpatient care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Day patient care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Overall satisfaction (VAS)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Satisfaction questionnaire (total group)
Number of subjects: 210
Study: 12411847

Group type: EXPERIMENTAL
Intervention: Hypodermoclysis with 1000 ml 5% dextrose in water infusion plus 140 mEq/L sodium chloride at 42 ml/hour per day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care with subcutaneous drugs (haloperidol 2.5 mg every 4 hours and/or metoclopramide 10 mg every 4 hours)
Number of subjects: 42
Study: 8636591

Group type: EXPERIMENTAL
Intervention: Barefoot
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standard low-heeled shoes (walking shoes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard high-heeled shoes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Own shoes
Number of subjects: 30
Study: 1524115

Group type: EXPERIMENTAL
Intervention: Levobunolol 0.5%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6385678

Group type: EXPERIMENTAL
Intervention: Hydralazine (149 +/- 11 mg daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 3711771

Group type: EXPERIMENTAL
Intervention: Breast screening
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Frequent self-examination (more than once a month)
Number of subjects: 132
Study: 28678111

Group type: EXPERIMENTAL
Intervention: Batroxobin (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) (Group T)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of Batroxobin and Tranexamic Acid (Group BT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 100
Study: 27376940

Group type: EXPERIMENTAL
Intervention: Hamstring graft
Number of subjects: 33

Group type: COMPARATOR
Intervention: Patellar tendon graft
Number of subjects: 33
Study: 25576896

Group type: EXPERIMENTAL
Intervention: Single dose of injectable powder of pure HSYA (IPPH) at doses of 25, 50, and 75 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multiple doses of 50 mg IPPH, once daily for 7 consecutive days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single and multiple dosing of IPPH
Number of subjects: 36
Study: 22731399

Group type: EXPERIMENTAL
Intervention: Terazosin (1 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 19926718

Group type: EXPERIMENTAL
Intervention: 5 microg nalfurafine hydrochloride
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: 2.5 microg nalfurafine hydrochloride
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study: 18972781

Group type: EXPERIMENTAL
Intervention: Light intensity of 100 mW/cm2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light intensity of 300 mW/cm2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light intensity of 500 mW/cm2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light intensity of 600 mW/cm2 (used for polymerization after bonding)
Number of subjects: 0
Study: 16649881

Group type: EXPERIMENTAL
Intervention: Self-system therapy (SST)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 45
Study: 14636195

Group type: EXPERIMENTAL
Intervention: 4% hydroquinone combined with 10% buffered glycolic acid, vitamins C and E, and sunscreen
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sunscreen alone
Number of subjects: 39
Study: 10895397

Group type: EXPERIMENTAL
Intervention: tolcapone (100 or 200 mg three times daily)
Number of subjects: 24
Study: 8644624

Group type: EXPERIMENTAL
Intervention: Chronic oral sotalol
Number of subjects: 0
Study: 1378685

Group type: EXPERIMENTAL
Intervention: Iloprost (3000ng infused into the graft)
Number of subjects: 0
Study: 6378158

Group type: EXPERIMENTAL
Intervention: Phenylephrine hydrochloride nose drops or nasal spray
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 31752756

Group type: EXPERIMENTAL
Intervention: 5-8 model for preoperative risk stratification
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: 5-8 model
Number of subjects: 748
Study: 28554375

Group type: EXPERIMENTAL
Intervention: Home-based psychoeducative intervention
Number of subjects: 20
Study: 24889731

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Saxagliptin (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both gliptins (Sitagliptin and Saxagliptin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Glimepiride (2 mg)
Number of subjects: 12
Study: 23916998

Group type: EXPERIMENTAL
Intervention: 5h sleep restriction
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal sleep
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 80 mg caffeine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 21859060

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine hydrochloride
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine hydrochloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (saline solution)
Number of subjects: 60
Study: 19251141

Group type: EXPERIMENTAL
Intervention: Primary posterior continuous curvilinear capsulorhexis with posterior optic buttonholing (PCCC-POBH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Primary posterior continuous curvilinear capsulorhexis (PCCC) without posterior optic buttonholing
Number of subjects: 30
Study: 16955184

Group type: EXPERIMENTAL
Intervention: Topical morphine gel 0.3%
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 28
Study: 14695665

Group type: EXPERIMENTAL
Intervention: Presence of specific viruses in middle ear fluids and nasopharyngeal aspirates
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Detection of rhinoviruses, enteroviruses, and respiratory syncytial virus (RSV)
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Overall virus detection methods
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: PCR-based methods for virus detection
Number of subjects: 940
Study: 11509270

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional analgesia (parenteral opiates)
Number of subjects: 200
Study: 9928856

Group type: EXPERIMENTAL
Intervention: High dose of aprotinin (Group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bacterial infection (Group C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Systemic Inflammatory Response Syndrome (SIRS) (Group D)
Number of subjects: 20
Study: 7988583

Group type: EXPERIMENTAL
Intervention: Anaesthetic solution injected into the perivascular axillary sheath (12 ml of a mixture of equal parts of 0.5% bupivacaine with 1:200,000 adrenaline and 2% lignocaine)
Number of subjects: 40
Study: 2472337

Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stitches
Number of subjects: 100
Study: 1102232

Group type: EXPERIMENTAL
Intervention: Butorphanol tartrate (1 mg)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Butorphanol tartrate (2 mg)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Butorphanol tartrate (4 mg)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Pentazocine (30 mg)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Pentazocine (60 mg)
Number of subjects: 262
Study: 30630555

Group type: EXPERIMENTAL
Intervention: group rumination-focused cognitive-behavioural therapy (RFCBT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: group CBT
Number of subjects: 131
Study: 31385880

Group type: EXPERIMENTAL
Intervention: High pressure 24 cm H2O and low pressure 20 cm H2O (very high positive end-expiratory pressure-very low driving pressure)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High pressure 24 cm H2O and low pressure 5 cm H2O (low positive end-expiratory pressure-high driving pressure)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High pressure 17 cm H2O and low pressure 5 cm H2O (low positive end-expiratory pressure-low driving pressure)
Number of subjects: 16
Study: 28727887

Group type: EXPERIMENTAL
Intervention: YAG laser vitreolysis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham YAG (control)
Number of subjects: 52
Study: 26562591

Group type: EXPERIMENTAL
Intervention: Alcohol Brief Intervention (ABI)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Screening alone (Control)
Number of subjects: 124
Study: 23760160

Group type: EXPERIMENTAL
Intervention: Sperm selection before freezing with hypotaurine supplementation (S-F/H+)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sperm selection before freezing without hypotaurine supplementation (S-F/H-)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sperm freezing after selection without hypotaurine supplementation (F-S/H-)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sperm freezing after selection with hypotaurine supplementation (F-S/H+)
Number of subjects: 64
Study: 21443271

Group type: EXPERIMENTAL
Intervention: Crotalidae polyvalent immune Fab (IV administration)
Number of subjects: 0
Study: 19539252

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1057
Study: 16939570

Group type: EXPERIMENTAL
Intervention: Apligraf
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Apligraf dermis only (without epidermis)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Polyurethane film
Number of subjects: 10
Study: 15521841

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (13-15 mg/kg/day) + Mycophenolate mofetil (1000 mg b.d.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid (13-15 mg/kg/day)
Number of subjects: 25
Study: 10966090

Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) as a conceptual model for generating interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: CQI as a general management philosophy
Number of subjects: 0
Study: 9254071

Group type: EXPERIMENTAL
Intervention: Mixed meal containing 63 g fat and 150,000 IU vitamin A
Number of subjects: 49
Study: 8485018

Group type: EXPERIMENTAL
Intervention: Sinemet CR (200 mg levodopa/50 mg carbidopa)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Madopar CR (100 mg levodopa/25 mg benserazide)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2442994

Group type: EXPERIMENTAL
Intervention: Ethmozine (600 to 900 mg/day in 3 equally divided doses)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ethmozine plus Propranolol (40 mg, 3 times daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Propranolol (40 mg, 3 times daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ethmozine plus Propranolol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ethmozine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination therapy (Ethmozine plus Propranolol)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ethmozine or combination therapy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ventricular function assessment
Number of subjects: 26
Study: 31552541

Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy (PPT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated group (Control)
Number of subjects: 60
Study: 29543126

Group type: EXPERIMENTAL
Intervention: Suspension-training movement program (6 weeks, two 1-hour sessions per week)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 27565230

Group type: COMPARATOR
Intervention: Inseminated
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Induced ovulation/inseminated (750 IU eCG, 500 IU hCG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Superovulated/inseminated (1500 IU eCG, 1000 IU hCG)
Number of subjects: 20
Study: 25473210

Group type: EXPERIMENTAL
Intervention: Rejuran®
Number of subjects: 72

Group type: COMPARATOR
Intervention: Yvoire‐Hydro®
Number of subjects: 72
Study: 23787062

Group type: EXPERIMENTAL
Intervention: Collaborative Stepped Care (CSC)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 163
Study: 20645010

Group type: COMPARATOR
Intervention: SLN negative (n = 1988)
Number of subjects: 2335

Group type: EXPERIMENTAL
Intervention: SLN-only positive (n = 296)
Number of subjects: 2335

Group type: EXPERIMENTAL
Intervention: Both SLN and NSN positive (n = 51)
Number of subjects: 2335
Study: 19337387

Group type: EXPERIMENTAL
Intervention: Salsalate (4.5 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salsalate (3.0 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salsalate (maximum tolerable dose, no tinnitus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16617028

Group type: EXPERIMENTAL
Intervention: Carbon ePTFE vascular grafts (n=130)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard ePTFE vascular grafts (n=135)
Number of subjects: 283
Study: 12748028

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 300
Study: 10986713

Group type: EXPERIMENTAL
Intervention: Operative 'end to end' surgery
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Percutaneous repair
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (non-operated patients)
Number of subjects: 73
Study: 8970352

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (LDD) 3 micrograms/kg/min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7948157

Group type: EXPERIMENTAL
Intervention: Brief intervention programme
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 221
Study: 3361170

Group type: EXPERIMENTAL
Intervention: Metoclopramide (1 mg/kg, 4 times every 2.5 hours), dexamethasone (3.8 mg, 4 times every 2.5 hours), antihistamine (10 mg, 2 times every 5 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no antiemetic agents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined antiemetic agents
Number of subjects: 0
Study: 31917608

Group type: EXPERIMENTAL
Intervention: DL suture‐bridge repair
Number of subjects: 70

Group type: COMPARATOR
Intervention: SL suture‐bridge repair
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 29502350

Group type: EXPERIMENTAL
Intervention: Premeal protein-enriched, dietary fiber-fortified bar (PFB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postmeal protein-enriched, dietary fiber-fortified bar (PFB)
Number of subjects: 30
Study: 28699295

Group type: EXPERIMENTAL
Intervention: Peyton's four-step approach
Number of subjects: 39

Group type: COMPARATOR
Intervention: See one, do one approach
Number of subjects: 39
Study: 25434773

Group type: COMPARATOR
Intervention: AP-DSD measurements
Number of subjects: 96

Group type: COMPARATOR
Intervention: TR-DSD measurements
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: AP-DSD and TR-DSD in Marfan patients
Number of subjects: 96

Group type: COMPARATOR
Intervention: DSR (DSD/VBD) in males
Number of subjects: 96

Group type: COMPARATOR
Intervention: AP-DSD and TR-DSD for discrimination
Number of subjects: 96
Study: 22616770

Group type: EXPERIMENTAL
Intervention: ThinPrep® Imaging System (TIS)
Number of subjects: 169917

Group type: COMPARATOR
Intervention: Manual screening (Control)
Number of subjects: 169917
Study: 21984028

Group type: EXPERIMENTAL
Intervention: Clonidine 1 μg/kg IV
Number of subjects: 84

Group type: COMPARATOR
Intervention: N/S 0.9% (placebo)
Number of subjects: 84
Study: 18287439

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced sonography
Number of subjects: 116

Group type: COMPARATOR
Intervention: Baseline sonography
Number of subjects: 116
Study: 16921047

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GemCis arm)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Gemcitabine alone (Gem arm)
Number of subjects: 195
Study: 12665684

Group type: EXPERIMENTAL
Intervention: Ascorbic acid-menadione
Number of subjects: 0
Study: 11024374

Group type: EXPERIMENTAL
Intervention: Intermittent aortic cross-clamping (IAC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Cardioplegic arrest (CA)
Number of subjects: 103
Study: 8784217

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) as add-on therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 0
Study: 2085059

Group type: EXPERIMENTAL
Intervention: 400 mg vitamin E (d‐alpha‐tocopherolacetate, V, n = 26)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 50 mg Diclofenac (D, n = 27)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 400 mg vitamin E (V)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 50 mg Diclofenac (D)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 53
Study: 492827

Group type: EXPERIMENTAL
Intervention: Pediatric telephone protocols administered by health assistants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current system in the emergency room
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pediatric telephone protocols
Number of subjects: 0
Study: 30980079

Group type: EXPERIMENTAL
Intervention: Fully robotic Ivor Lewis esophageal resection (RAMIE4)
Number of subjects: 100
Study: 29089196

Group type: EXPERIMENTAL
Intervention: Customized functional wrist orthosis (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No orthotic (control group, n = 15)
Number of subjects: 30
Study: 28476313

Group type: EXPERIMENTAL
Intervention: Bioresorbable mesh
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Titanium mesh
Number of subjects: 8
Study: 25818032

Group type: EXPERIMENTAL
Intervention: Instillation of 5 ml 2% lidocaine gel in the urethra 5 minutes before catheterization
Number of subjects: 94

Group type: COMPARATOR
Intervention: Lubrication of the distal part of the catheter with 5 ml 2% lidocaine gel
Number of subjects: 94
Study: 22970751

Group type: EXPERIMENTAL
Intervention: Single miniscrews (group A, n = 12)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dual miniscrews (group B, n = 13)
Number of subjects: 25
Study: 21710870

Group type: EXPERIMENTAL
Intervention: Essential oil-containing mouth rinse (Cool Mint Listerine Antiseptic)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 36
Study: 19853691

Group type: EXPERIMENTAL
Intervention: Trials reporting race/ethnicity information
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: NIH-funded trials
Number of subjects: 156
Study: 17095338

Group type: EXPERIMENTAL
Intervention: ALTU‐135 (5000 units of lipase)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: ALTU‐135 (25000 units of lipase)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: ALTU‐135 (100000 units of lipase)
Number of subjects: 117
Study: 14973217

Group type: EXPERIMENTAL
Intervention: 1-cm margin of excision
Number of subjects: 900

Group type: COMPARATOR
Intervention: 3-cm margin of excision
Number of subjects: 900
Study: 11207991

Group type: EXPERIMENTAL
Intervention: Albumin infusion (1 g/kg bodyweight, i.v., during the first 2 h of phototherapy)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (only phototherapy)
Number of subjects: 58